Skip to main content

Table 2 Antibody titers of predominant responses in selected bleeds of XMRV-infected macaques and goat polyclonal antibodies to MuLV.

From: Characterization of antibodies elicited by XMRV infection and development of immunoassays useful for epidemiologic studies

Sample Days post XMRV Infection Antibody Titers by ARCHITECT CMIAs
  1st
Infection
2nd
Infection
Immuni-
zation
Anti-gp70 Anti-p15E Anti-p30
RIl-10 42    800 40 2
  134    3,200 160 10
  167 9   128,000 12,800 640
  210 52   32,000 800 80
  291 133 16 16,000 8,000 4,000
RYh-10 42    1,600 80 10
  134    1,600 80 10
  167 9   32,000 6,400 640
  210 52   8,000 400 80
  291 133 16 4,000 4,000 2,000
RLq-10 42    800 80 1
  134    800 160 1
Anti-MuLV pAb 16,000 32,000 64,000
Anti-Env pAb 10,000   
Anti-His Mab 0.039 nM   1.18 nM
Anti-p30 Mab    0.56 nM
  1. Antibody titers were determined by the three direct gp70, p15E and p30 CMIAs on samples serially diluted with negative normal human plasma, and expressed as the reciprocal of the bleed dilution giving a reactive result. For comparison, detection limits of the anti-His and anti-p30 monoclonal antibodies were also listed.